Literature DB >> 12949374

Lutein interacts with ascorbic acid more frequently than with alpha-tocopherol to alter biomarkers of oxidative stress in female zucker obese rats.

Shirley Blakely1, Arnetra Herbert, Michelle Collins, Mamie Jenkins, Geraldine Mitchell, Erich Grundel, Karen R O'Neill, Frederick Khachik.   

Abstract

The influence of dietary lutein, with and without moderate amounts of vitamin C (VC) or vitamin E (VE), on biomarkers of oxidative stress was examined in rats. Nine groups of immature Zucker obese (fa/fa) and lean female rats (8/group) consumed ad libitum for 8 wk the AIN-93G diet (Control) to which was added either dl-alpha-tocopherol acetate (VE) at 0.60 mg/kg or ascorbic acid (VC) at 0.75 mg/kg diet. Each of these diets contained lutein oil (FloraGlo) at 0.5 (Lut0.5) or 1.0 (Lut1.0) mg/kg diet. Weight gain, food efficiency and relative liver weight were higher in obese than in lean rats. Although liver malondialdehyde (MDA) concentrations were significantly higher in obese than in lean rats, levels were significantly lower in obese rats fed VE, VE-Lut and VC-Lut0.5 compared with other obese groups. The accumulation of alpha-tocopherol in liver was 6- and 3-times greater in the VE and VE-Lut1.0 groups, respectively, compared with the obese and lean control groups. Lutein reduced the activity of superoxide dismutase (SOD) in obese rats, independent of VC or VE, and raised the activity of glutathione peroxidase to higher levels in lean rats when combined with VC. Plasma insulin levels were dramatically higher in obese compared with lean rats, but significantly lower in obese rats fed VC-Lut0.5, VE-Lut1.0 and Lut1.0 compared with the Control group. These results suggest that lutein independently reduces the activity of SOD and alters more biomarkers of oxidative stress when combined with vitamin C than with vitamin E, and that vitamin E reduces liver lipid peroxidation in obese rats when the accumulation of liver alpha-tocopherol is very high.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949374     DOI: 10.1093/jn/133.9.2838

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat.

Authors:  Yuriy Slyvka; Sharon R Inman; Ramiro Malgor; Edwin J Jackson; Jennifer Yee; Olusayo Oshogwemoh; John Adame; Felicia V Nowak
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

2.  Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration.

Authors:  Eunyoung Cho; Susan E Hankinson; Bernard Rosner; Walter C Willett; Graham A Colditz
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

3.  Cereal based diets modulate some markers of oxidative stress and inflammation in lean and obese Zucker rats.

Authors:  Damien P Belobrajdic; Yan Y Lam; Mark Mano; Gary A Wittert; Anthony R Bird
Journal:  Nutr Metab (Lond)       Date:  2011-05-03       Impact factor: 4.169

4.  Effects of lutein or lutein in combination with vitamin C on mRNA expression and activity of antioxidant enzymes and status of the antioxidant system in SD rats.

Authors:  Min-Hae Song; Eu-Chul Shin; Dae-Youn Hwang; In-Surk Jang
Journal:  Lab Anim Res       Date:  2015-09-30

Review 5.  Factors Differentiating the Antioxidant Activity of Macular Xanthophylls in the Human Eye Retina.

Authors:  Justyna Widomska; Wieslaw I Gruszecki; Witold K Subczynski
Journal:  Antioxidants (Basel)       Date:  2021-04-14

Review 6.  Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration-Neurodegenerative Disease.

Authors:  Małgorzata Mrowicka; Jerzy Mrowicki; Ewa Kucharska; Ireneusz Majsterek
Journal:  Nutrients       Date:  2022-02-16       Impact factor: 5.717

Review 7.  A Review on Antidiabetic Activity of Centaurea spp.: A New Approach for Developing Herbal Remedies.

Authors:  Samaneh Fattaheian-Dehkordi; Reza Hojjatifard; Mina Saeedi; Mahnaz Khanavi
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-05       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.